Human Fetuin-A (Alpha-2-HS-Glycoprotein) ELISA Kit (with Control)

$453.00

Catalog Number: EG3501-7

This assay employs a quantitative enzyme immunoassay technique that measures the specified antigen in samples.
Product Size:96 Well Plate

Additional information

Format

Sandwich ELISA

Entrez Gene

197

Components

Biotinylated Human Fetuin-A Antibody, Chromogen Substrate (1x), Human Fetuin-A Microplate, Human Fetuin-A Standard, MIX Diluent Concentrate (10x), Positive Control, Sealing Tapes, SP Conjugate (100x), Stop Solution (1x), Wash Buffer Concentrate (20x)

TIme

4 hours

Sensitivity

1.4 ng/ml

Range

3.125 – 200 ng/ml

Samples Type

CSF, Milk, Plasma, Saliva, Serum, Urine

Associated Disease

Alzheimer's Disease, Cardiovascular, Kidney Failure

Species

Human

UniProt

P02765

Storage

Refer to component labels for details

Plex

1

Usage

For Research Use Only, Not To Be Used For Diagnostic Purposes

Documentation

Publications (32 results)

Please use discretion when following external links; Assaypro cannot guarantee the validity and security of all citation links provided.

The Evaluation of Serum Tumor Necrosis Factor-Like Weak Inducer of Apoptosis, Interleukin-6, Fetuin-A, Homeostatic Model Assessment-Insulin Resistance, and …

  • https://pmc.ncbi.nlm.nih.gov/articles/PMC6542214/
  • SAĞ Sinem, D Güzel, MS Sağ… - Archives of …, 2018 - pmc.ncbi.nlm.nih.gov
  • Objectives This study aims to examine the relationship of serum tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) levels with interleukin (IL)-6, tumor necrosis factor-alpha (…

Are serum protein biomarkers derived from proteomic analysis useful in screening for trisomy 21 at 11–13 weeks?

  • https://karger.com/fdt/article-abstract/30/1/53/135789
  • AL Mastricci, R Akolekar, R Kuppusamy… - Fetal diagnosis and …, 2011 - karger.com
  • Objective: The aim of this study is to identify potential biomarkers for fetal trisomy 21 from previous publications using proteomic techniques and examine the potential value of such …

Analysis of an Indian diabetes prevention programme on association of adipokines and a hepatokine with incident diabetes

Fetuin-A and its association with disease activity in psoriatic arteritis

The role of cystatin-C and fetuin-A in the determination of early atherosclerotic risk in psoriasis patients

Fetuin-A levels determine cardiovascular risk in young diabetic patients

Relationship of fibroblast growth factor 23 and fetuin-A to coronary atherosclerosis

Association of fetuin A, adiponectin, interleukin 10 and total antioxidant capacity with IVF outcomes

Fetuin-A is related to syndesmophytes in patients with ankylosing spondylitis: a case control study

Preventive roles of swimming exercise and pioglitazone treatment on hepatic dysfunction in a rat model of metabolic syndrome

Impact of Different Doses of Sucrose on the Liver Function and Ultrastructure in Rats

Effect of pioglitazone on hepatic ultra-structure and metabolic changes induced by a high sucrose diet in rats

Serum levels of fetuin a and 8-hydroxydeoxyguanosine in morbidly obese subjects. Exp Clin Endocrinol Diabetes

The Effect of Regular Colchicine Treatment on Biomarkers Related with Vascular Injury in Newly Diagnosed Patients with Familial Mediterranean Fever

Analysis of acute-phase proteins, AHSG, C3, CLI, HP and SAA, reveals distinctive expression patterns associated with breast, colorectal and lung cancer

Are Serum Protein Biomarkers Derived from Proteomic Analysis Useful in Screening for Trisomy 21 at 11-13 Weeks?

Serum Visfatin and Fetuin-A Levels and Glycemic Control in Patients with Obese Type 2 Diabetes Mellitus

* Susairaj P et al. (2021) Analysis of an Indian diabetes prevention programme on association of adipokines and a hepatokine with incident diabetes. Sci Rep. 11(1):20327.

* Gulle S et al. (2021) Fetuin-A and its association with disease activity in psoriatic arteritis. Ulus Romatol J. 13(2):47-53.

* Demirbas A et al. (2020) The role of cystatin-C and fetuin-A in the determination of early atherosclerotic risk in psoriasis patients. Dermatol Ther. 33(6):e13898.

* Keskin M et al. (2017) Fetuin-A levels determine cardiovascular risk in young diabetic patients. Biomedical Research 28(15):6767-6772

* Akin F et al. (2015) Relationship of fibroblast growth factor 23 and fetuin-A to coronary atherosclerosis. J Diabetes Complications. 29(4):550-5

* Yen M et al. (2014) Association of fetuin A, adiponectin, interleukin 10 and total antioxidant capacity with IVF outcomes. Iran J Reprod Med 12(11):747-754

* Tuylu T et al. (2014) Fetuin-A is related to syndesmophytes in patients with ankylosing spondylitis: a case control study. CLINICS 69(10):688-693

* Sakr HF et al. (2014) Preventive roles of swimming exercise and pioglitazone treatment on hepatic dysfunction in a rat model of metabolic syndrome. Can. J. Physiol. Pharmacol. 92: 162-170.

* Morsy MD et al.(2014) Impact of Different Doses of Sucrose on the Liver Function and Ultrastructure in Rats. Med. J. Cairo Univ. 82(1): 133-144

* Morsy MD et al. (2014) Effect of pioglitazone on hepatic ultra-structure and metabolic changes induced by a high sucrose diet in rats. American Journal of Applied Sciences 11 (7): 1087-1098

* Himmetoglu S et al. (2013) Himmetoglu S et al. (2013) Serum levels of fetuin a and 8-hydroxydeoxyguanosine in morbidly obese subjects. Exp Clin Endocrinol Diabetes. 121(08): 505-508.

* Sari I et al. (2012) The Effect of Regular Colchicine Treatment on Biomarkers Related with Vascular Injury in Newly Diagnosed Patients with Familial Mediterranean Fever. Inflammation. 35(3):1191-7.

* Dowling P et al (2012) Analysis of acute-phase proteins, AHSG, C3, CLI, HP and SAA, reveals distinctive expression patterns associated with breast, colorectal and lung cancer. Int J Cancer. 131(4):911-923

* Mastricci AL et al. (2011) Are Serum Protein Biomarkers Derived from Proteomic Analysis Useful in Screening for Trisomy 21 at 11-13 Weeks? Fetal Diagn Ther. 30(1):53-59

* Gunduz FO et al. (2011) Serum Visfatin and Fetuin-A Levels and Glycemic Control in Patients with Obese Type 2 Diabetes Mellitus. Diabetes Metab J 35:523-528

Loading data...